검색 상세

Development of melittin modified lipid nanoparticles for intranasal administration vaccination

목차

1. Introduction 1
1.1. mRNA lipid nanoparticle (LNP) 1
1.2. Vaccine delivery system 7
1.3. Hypothesis 13
2. Materials and Methods 16
2.1. Materials 16
2.2. Conjugation of Lipid-Melittin (DOPE-MEL) 17
2.3. Fabrication of melittin modified lipid nanoparticles (LNP-MEL) 18
2.4. In vitro cellular uptake efficiency of LNP-MEL 19
2.5. Mucus layer penetration efficiency of LNP-MEL 21
3. Results and Discussion 24
3.1. Characterization of LNP-MEL 24
3.2. Enhanced cellular uptake of LNP-MEL in a monolayer model 27
3.3. Enhanced endosomal escape efficiency of LNP-MEL in a cellular monolayer model 31
3.4. Enhanced cellular uptake of LNP-MEL on mucus layered cell model 35
4. Conclusion 40
5. References 42

more